Discovery Laboratories Inc. (NASDAQ:WINT) was up 13.7% during mid-day trading on Thursday . The stock traded as high as $2.69 and last traded at $2.65, with a volume of 72,328 shares changing hands. The stock had previously closed at $2.33.

Several equities research analysts have recently issued reports on WINT shares. HC Wainwright started coverage on Discovery Laboratories in a report on Friday, April 22nd. They set a “buy” rating and a $8.00 price target for the company. Zacks Investment Research lowered Discovery Laboratories from a “buy” rating to a “hold” rating in a report on Thursday, July 21st.

The firm has a 50 day moving average of $2.02 and a 200-day moving average of $2.19. The company’s market capitalization is $24.26 million.

Discovery Laboratories (NASDAQ:WINT) last released its earnings results on Wednesday, August 10th. The company reported ($1.29) earnings per share for the quarter, beating the consensus estimate of ($1.64) by $0.35. Equities research analysts predict that Discovery Laboratories Inc. will post ($5.87) earnings per share for the current year.

Windtree Therapeutics, Inc, formerly Discovery Laboratories, Inc, is a biotechnology company. The Company is focused on developing KL4 surfactant therapies for respiratory diseases and other potential applications. The Company operates through the research and development of products focused on surfactant therapies for respiratory disorders and diseases, and the manufacture and commercial sales of approved products segment.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.